Loading...
XSHG
605077
, Last price  
Name

Zhejiang Huakang Pharmaceutical Co Ltd

Chart & performance

D1W1MN
XSHG:605077 chart
P/E
—
P/S
—
EPS
0.88
Vol. 1Y
—
Shs. 5Y
6.36%
Rev. 5Y
25.99%
Div Yld LY
—
Div Yld TTM
—
Revenues
4.19b
+49.15%
763,338,300924,633,0721,399,742,8351,510,856,3781,319,652,4651,594,015,8002,200,023,0942,782,695,5312,808,435,8244,188,750,772
Net income
200m
-25.40%
28,710,70055,940,159199,378,901270,113,641307,167,240236,708,876319,277,845371,452,318268,483,891200,299,376
CFO
424m
+189.70%
93,015,10080,560,662140,971,643281,308,013335,241,828264,320,635271,977,255619,469,493146,496,348424,398,386
Dividend
Jun 17, 20260.3 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Huakang Pharmaceutical Co., Ltd. is an international company that focuses on the investigation, manufacturing, and worldwide sale of polyols. Its extensive product range includes xylitol, a polyol with a sweetness level comparable to sugar. Other significant offerings are sorbitol, a white crystalline sugar alcohol, and maltitol, another variety of sugar alcohol. The company also produces xylose, an essential ingredient for making xylitol, and L-arabinos, which can function as a sugar substitute or various additives. The firm's operations are based in Kaihua County, China.
IPO date
Feb 09, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT